Endurant Capital Management LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2021$3,920,000
-50.1%
73,914
-37.3%
0.95%
-56.2%
Q2 2021$7,857,000
+367.4%
117,904
+678.8%
2.16%
+392.9%
Q1 2021$1,681,000
-53.7%
15,139
-63.6%
0.44%
-59.2%
Q3 2020$3,630,000
+40.0%
41,607
+43.8%
1.07%
+655.6%
Q2 2020$2,592,000
-36.9%
28,937
-11.2%
0.14%
-90.4%
Q3 2019$4,111,000
+602.7%
32,594
+387.1%
1.48%
+538.5%
Q1 2019$585,0006,6910.23%
Other shareholders
HAEMONETICS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders